• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Empowering oncologists: a practical approach to overcoming barriers to clinical trial enrolment.

作者信息

Jiang Changchuan, Nipp Ryan D, Zhang Tian

机构信息

Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Nat Rev Clin Oncol. 2025 Jun 3. doi: 10.1038/s41571-025-01038-6.

DOI:10.1038/s41571-025-01038-6
PMID:40461801
Abstract
摘要

相似文献

1
Empowering oncologists: a practical approach to overcoming barriers to clinical trial enrolment.增强肿瘤学家的能力：克服临床试验入组障碍的实用方法。
Nat Rev Clin Oncol. 2025 Jun 3. doi: 10.1038/s41571-025-01038-6.
2
Electronic informed consent: effects on enrolment, practical and economic benefits, challenges, and drawbacks-a systematic review of studies within randomized controlled trials.电子知情同意：对入组的影响、实际和经济获益、挑战和缺陷——一项在随机对照试验中研究的系统综述。
Trials. 2023 Feb 21;24(1):127. doi: 10.1186/s13063-022-06959-6.
3
Barriers and solutions for healthcare professionals to involve patients as partners in oncology research: Project RISE.医疗保健专业人员让患者成为肿瘤学研究伙伴的障碍与解决方案：RISE项目
Future Oncol. 2025 Jun 11:1-10. doi: 10.1080/14796694.2025.2514415.
4
Determinants of enrolment rate in 397 clinical trials for healing diabetic foot ulcers: a systematic review.397项治愈糖尿病足溃疡临床试验的入组率决定因素：一项系统评价
BMJ Open. 2025 Jul 6;15(7):e095512. doi: 10.1136/bmjopen-2024-095512.
5
Barriers to Clinical Trial Enrollment: KCSG Survey-Based Perspectives of Medical Oncologists, Patients, and Their Caregivers.
Cancer Res Treat. 2025 Jul 7. doi: 10.4143/crt.2025.523.
6
Potential barriers to implementation of next-generation sequencing in cancer management: a U.S. Physician-based survey.癌症管理中实施下一代测序的潜在障碍：一项基于美国医生的调查。
Future Oncol. 2025 Jan;21(2):231-239. doi: 10.1080/14796694.2024.2430725. Epub 2024 Nov 28.
7
Barriers to patient enrolment in phase III cancer clinical trials: interviews with clinicians and pharmaceutical industry representatives.癌症三期临床试验中患者入组的障碍：对临床医生和制药行业代表的访谈。
BMJ Open. 2022 Feb 17;12(2):e055165. doi: 10.1136/bmjopen-2021-055165.
8
A systematic review of techniques and interventions for improving adherence to inclusion and exclusion criteria during enrolment into randomised controlled trials.系统评价改善随机对照试验纳入和排除标准依从性的技术和干预措施。
Trials. 2010 Feb 23;11:17. doi: 10.1186/1745-6215-11-17.
9
Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.参与癌症临床试验的障碍：对患者报告因素的荟萃分析和系统评价
Lancet Oncol. 2006 Feb;7(2):141-8. doi: 10.1016/S1470-2045(06)70576-9.
10
What Factors Affect Voluntary Uptake of Community-Based Health Insurance Schemes in Low- and Middle-Income Countries? A Systematic Review and Meta-Analysis.哪些因素影响低收入和中等收入国家基于社区的健康保险计划的自愿参保率？一项系统评价与荟萃分析。
PLoS One. 2016 Aug 31;11(8):e0160479. doi: 10.1371/journal.pone.0160479. eCollection 2016.

本文引用的文献

1
AI meets informed consent: a new era for clinical trial communication.人工智能与知情同意：临床试验沟通的新时代。
JNCI Cancer Spectr. 2025 Mar 3;9(2). doi: 10.1093/jncics/pkaf028.
2
Matching patients to clinical trials with large language models.利用大型语言模型为患者匹配临床试验。
Nat Commun. 2024 Nov 18;15(1):9074. doi: 10.1038/s41467-024-53081-z.
3
National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data.基于癌症委员会认证数据的癌症患者参与临床研究的全国估计。
J Clin Oncol. 2024 Jun 20;42(18):2139-2148. doi: 10.1200/JCO.23.01030. Epub 2024 Apr 2.
4
Provider motivations and barriers to cancer clinical trial screening, referral, and operations: Findings from a survey.医疗机构开展癌症临床试验筛选、转诊和运营的动机和障碍：一项调查研究结果。
Cancer. 2024 Jan 1;130(1):68-76. doi: 10.1002/cncr.35044. Epub 2023 Oct 18.
5
"When Offered to Participate": A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials.“被邀请参与时”：关于患者同意参与癌症临床试验的系统评价与荟萃分析
J Natl Cancer Inst. 2021 Mar 1;113(3):244-257. doi: 10.1093/jnci/djaa155.
6
Barriers to Participation in Therapeutic Clinical Trials as Perceived by Community Oncologists.社区肿瘤学家对参与治疗性临床试验的障碍的看法。
JCO Oncol Pract. 2020 Sep;16(9):e849-e858. doi: 10.1200/JOP.19.00662. Epub 2020 Apr 2.
7
A study of motivations and expectations of patients seen in phase 1 oncology clinics.一项关于在肿瘤学一期诊所就诊患者的动机和期望的研究。
Cancer. 2016 Nov 15;122(22):3501-3508. doi: 10.1002/cncr.30235. Epub 2016 Sep 26.
8
The behaviour change wheel: a new method for characterising and designing behaviour change interventions.行为改变轮：一种描述和设计行为改变干预措施的新方法。
Implement Sci. 2011 Apr 23;6:42. doi: 10.1186/1748-5908-6-42.